Kayne Anderson Rudnick Investment Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-51
Closed -$3K 691
2022
Q1
$3K Buy
+51
New +$2.7K ﹤0.01% 588
2018
Q1
Sell
-5,572
Closed -$367K 360
2017
Q4
$367K Sell
5,572
-628,861
-99% -$40M ﹤0.01% 321
2017
Q3
$37.9M Sell
634,433
-68,744
-10% -$4.09M 0.34% 83
2017
Q2
$45.6M Buy
703,177
+29,347
+4% +$1.85M 0.46% 70
2017
Q1
$42.1M Buy
673,830
+27,860
+4% +$1.68M 0.46% 62
2016
Q4
$37.3M Buy
645,970
+38,939
+6% +$2.3M 0.44% 64
2016
Q3
$36.1M Buy
607,031
+175,036
+41% +$10.8M 0.45% 65
2016
Q2
$26.8M Buy
431,995
+29,671
+7% +$1.83M 0.4% 67
2016
Q1
$24.8M Buy
+402,324
New +$23.7M 0.4% 68
2014
Q1
Sell
-10,207
Closed -$495K 302
2013
Q4
$495K Sell
10,207
-10,742
-51% -$503K 0.01% 250
2013
Q3
$910K Buy
20,949
+468
+2% +$20K 0.02% 225
2013
Q2
$839K Buy
+20,481
New +$854K 0.02% 220

Other funds holding XRAY

Kayne Anderson Rudnick Investment Management's XRAY Position: Q2 2022 in Review

Kayne Anderson Rudnick Investment Management sold out of Dentsply Sirona (XRAY) in Q2 2022, closing a stake of 51 shares — an estimated $3K sold.

Kayne Anderson Rudnick Investment Management first reported a position in XRAY in Q2 2013 and held it in 12 quarters. The position peaked at $45.6M in Q2 2017. 471 funds tracked by Wall St. Rank hold XRAY as of Q2 2022.

  • Kayne Anderson Rudnick Investment Management reported no remaining Dentsply Sirona position as of Q2 2022 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 51 Dentsply Sirona shares in Q2 2022, an estimated $3K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Dentsply Sirona in Q2 2013 and held it in 12 quarters.
  • Kayne Anderson Rudnick Investment Management's Dentsply Sirona position peaked at $45.6M in Q2 2017.
  • 471 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2022.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q2 2022, filed 12 Aug 2022.